<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04193176</url>
  </required_header>
  <id_info>
    <org_study_id>7264-042</org_study_id>
    <secondary_id>2019-002321-29</secondary_id>
    <secondary_id>MK-7264-042</secondary_id>
    <nct_id>NCT04193176</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)</brief_title>
  <official_title>A Phase 3b Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Gefapixant in Women With Chronic Cough and Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of gefapixant, in improving
      symptoms of cough-induced stress urinary incontinence (SUI) in adult female participants with
      refractory or unexplained chronic cough. The primary hypothesis is that gefapixant is
      superior to placebo in reducing the frequency of cough-induced SUI episodes over 12 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2020</start_date>
  <completion_date type="Anticipated">May 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 11, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent change from baseline in average daily cough-induced stress urinary incontinence (SUI) episodes at Week 12</measure>
    <time_frame>Baseline, Week 12</time_frame>
    <description>Cough-induced SUI episodes will be assessed using an event-driven electronic Incontinence Diary where the participant will record the main cause of each urinary incontinence episode as coughing, another stress reason, or other cause. Episodes of incontinence will be recorded for the week before baseline and treatment visit. Average daily cough induced SUI episodes will be calculated as (sum of daily cough-induced SUI episodes in a week)/number of days recorded. The baseline measure will be defined as the 7-day average daily value immediately prior to initial administration of study intervention. Percentage change in average-daily cough-induced SUI episodes will be calculated as (post baseline minus baseline)/baseline x 100.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with one or more adverse events (AEs)</measure>
    <time_frame>Up to ~Week 14</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The percentage of participants with one or more AEs will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who discontinue study drug due to an AE</measure>
    <time_frame>Up to Week 12</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The percentage of participants who discontinue study drug due to an AE will be calculated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Cough</condition>
  <arm_group>
    <arm_group_label>Gefapixant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive gefapixant at a dose of 45 mg administered as an oral tablet twice daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive placebo matching gefapixant, administered as an oral tablet twice daily for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gefapixant</intervention_name>
    <description>Administered twice daily as an oral tablet of 45 mg</description>
    <arm_group_label>Gefapixant</arm_group_label>
    <other_name>MK-7264</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered twice daily as a placebo oral tablet matching gefapixant</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has a chest radiograph or computed tomography scan of the thorax (within 5 years of
             Screening and after the onset of chronic cough) not demonstrating any abnormality
             considered to be significantly contributing to the chronic cough or any other lung
             disease

          -  Has chronic cough (defined as duration of &gt;8 weeks after onset of cough symptoms) for
             ≥12 months

          -  Has a diagnosis of refractory chronic cough or unexplained chronic cough

          -  Has symptoms of SUI, defined as involuntary loss of urine on effort, physical
             exertion, or on sneezing or coughing, for ≥3 months

          -  Is a female who is not pregnant, not breastfeeding, not of childbearing potential, or
             agrees to follow contraceptive guidance

        Exclusion Criteria:

          -  Is a current smoker

          -  Has given up smoking within 12 months of screening

          -  Is a former smoker with a smoking history greater than 20 pack-years (1 pack of 20
             cigarettes per day for 20 years)

          -  Has a history of respiratory tract infection or recent change in pulmonary status
             within 4 weeks of screening

          -  Has a history of chronic bronchitis

          -  Has a history of surgery to treat SUI within 1 year of screening

          -  Has a history of other specialized treatments for SUI, including intravesical balloon
             or urethral bulking agent therapy

          -  Has other external incontinence device currently or within 1 month of screening

          -  Has a history of Grade 3 or higher pelvic organ prolapse previously documented or
             diagnosed on screening

          -  Has a neurogenic bladder

          -  Has a history of adult nocturnal incontinence

          -  Has a history of continuous urine leakage within 1 month of screening

          -  Has a history of interstitial cystitis

          -  Has a history of neurological disease or injury

          -  Has active or recurrent urinary tract infection

          -  Has a history of having a permanent urinary catheter or any urinary catheterization
             within 3 months of screening

          -  Has a history of malignancy ≤5 years prior to signing informed consent

          -  Is a user of recreational or illicit drugs or a recent history (within the last year)
             of drug or alcohol abuse

          -  Has a known allergy to gefapixant or its excipients

          -  Has donated or lost ≥1 unit (~300 mL) of blood within 8 weeks prior to first dose of
             gefapixant

          -  Requires certain medications and/or other therapies that may impact their cough or
             bladder

          -  Has previously received gefapixant

          -  Is currently participating or has participated in an interventional clinical study
             within 30 days of participating in this current study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Toll Free Number</last_name>
    <phone>1-888-577-8839</phone>
    <email>Trialsites@merck.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center for Clinical Trials, LLC ( Site 0021)</name>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <zip>90723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>562-633-5101</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Health Awareness, Inc. ( Site 0038)</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>561-741-2033</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Well Pharma Medical Research, Corp. ( Site 0040)</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>305-665-4818</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lenus Research &amp; Medical Group Llc ( Site 0007)</name>
      <address>
        <city>Sweetwater</city>
        <state>Florida</state>
        <zip>33172</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>305-592-4692</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Pulmonary Research Institute, LLC ( Site 0008)</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>407-740-8078</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Paul A. Shapero, MD ( Site 0037)</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>207-947-8658</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chesapeake Clinical Research, Inc ( Site 0022)</name>
      <address>
        <city>White Marsh</city>
        <state>Maryland</state>
        <zip>21162</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>410-931-1966</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alliance for Multispecialty Reseach, LLC ( Site 0035)</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89119</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>702-597-9825</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albuquerque Clinical Trials ( Site 0019)</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>505-224-7407</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>American Health Research ( Site 0027)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>704-926-8042</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research of Gastonia ( Site 0016)</name>
      <address>
        <city>Gastonia</city>
        <state>North Carolina</state>
        <zip>28054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>704-675-7144</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>PMG Research of Wilmington ( Site 0004)</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>910-799-5500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>AAPRI Clinical Research Institute ( Site 0031)</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02886</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>401-681-4960</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diagnostics Research Group ( Site 0013)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>210-692-7157</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>TPMG Clinical Research ( Site 0025)</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>757-232-8836</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tidewater Physician Multispecialty Group, PC ( Site 0028)</name>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <zip>23188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>757-707-3999</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bellingham Asthma &amp; Allergy ( Site 0006)</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>360-733-5733</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Medico Dra De Salvo ( Site 0300)</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1426ABP</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+541147815331</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Investigaciones en Patologias Respiratorias ( Site 0302)</name>
      <address>
        <city>Tucuman</city>
        <zip>T4000IAQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+543814212611</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Wehgartner-Winkler ( Site 0906)</name>
      <address>
        <city>Augsburg</city>
        <state>Bayern</state>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4982147866826</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentrum fuer ambulante pneumologische Forschung Marburg GbR ( Site 0900)</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+496421270723</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ballenberger Freytag Wenisch Institut fuer klinische Forschung GmbH ( Site 0905)</name>
      <address>
        <city>Neu-Isenburg</city>
        <state>Hessen</state>
        <zip>63263</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+49610280 9710</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologicum im Suedstadtforum ( Site 0908)</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30173</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+495111691755</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bethel Soluciones Medicas S.A. ( Site 0506)</name>
      <address>
        <city>Guatemala</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50240239064</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0500)</name>
      <address>
        <city>Guatemala</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50252012851</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Medica Especializada en Neumologia y Tisiologia ( Site 0504)</name>
      <address>
        <city>Guatemala</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50223314800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Medica Especializada en Neumologia ( Site 0502)</name>
      <address>
        <city>Guatemala</city>
        <zip>01011</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50255135640</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Private Clinic ( Site 0505)</name>
      <address>
        <city>Guatemala</city>
        <zip>01011</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50252045740</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Privada Dr. Jose Francisco Flores Lopez ( Site 0503)</name>
      <address>
        <city>Guatemala</city>
        <zip>01015</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50223857431</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center ( Site 1102)</name>
      <address>
        <city>Petah Tikva</city>
        <state>HaMerkaz</state>
        <zip>4941492</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+97239377221</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center ( Site 1103)</name>
      <address>
        <city>Rehovot</city>
        <state>HaMerkaz</state>
        <zip>7610001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+97289441438</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center ( Site 1101)</name>
      <address>
        <city>Ramat Gan</city>
        <state>Tell Abib</state>
        <zip>5265601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+97235307096</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sourasky Medical Center ( Site 1100)</name>
      <address>
        <city>Tel-Aviv</city>
        <state>Tell Abib</state>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+97236974961</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center ( Site 1107)</name>
      <address>
        <city>Jerusalem</city>
        <state>Yerushalayim</state>
        <zip>9103102</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>972266666278</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah Ein Karem Jerusalem ( Site 1108)</name>
      <address>
        <city>Jerusalem</city>
        <state>Yerushalayim</state>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+97226776817</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital ( Site 1502)</name>
      <address>
        <city>Wonju-si</city>
        <state>Kang-won-do</state>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+82337410927</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Konkuk University Medical Center ( Site 1504)</name>
      <address>
        <city>Seoul</city>
        <state>Seoul-teukbyeolsi [Seoul]</state>
        <zip>05030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+82220305076</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center ( Site 1505)</name>
      <address>
        <city>Seoul</city>
        <state>Seoul-teukbyeolsi [Seoul]</state>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+82230104650</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>RSBHI Belgorod regional clinical hospital of Prelate Ioasafa ( Site 1416)</name>
      <address>
        <city>Belgorod</city>
        <state>Belgorodskaya Oblast'</state>
        <zip>308007</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79803703374</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Perm Clinical Center of the Federal Medical and Biological Agency ( Site 1450)</name>
      <address>
        <city>Perm</city>
        <state>Permskiy Kray</state>
        <zip>614052</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+7(342)212-35-59</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Limited Liability Company Kurator ( Site 1424)</name>
      <address>
        <city>St. Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>196240</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79818518150</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State health Agency Ulyanovsk regional clinical hospital ( Site 1414)</name>
      <address>
        <city>Ulyanovsk</city>
        <state>Ul'yanovskaya Oblast'</state>
        <zip>432063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79033201711</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Voronezh Regional Clinical Hospital #1 ( Site 1440)</name>
      <address>
        <city>Voronezh</city>
        <state>Voronezskaja Oblast'</state>
        <zip>394066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79601024240</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SBCIH of the Yaroslavl region Central city hospital ( Site 1428)</name>
      <address>
        <city>Yaroslavl</city>
        <state>Yaroslavskaya Oblast'</state>
        <zip>150040</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79159752515</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Santiago ( Site 1805)</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruna [La Coruna]</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34981951173</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Maranon ( Site 1808)</name>
      <address>
        <city>Madrid</city>
        <state>Madrid, Comunidad De</state>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34915868326</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center of LLC Medical Clinic Blahomed ( Site 2815)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>01023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380936306646</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SE Road Clinical Hospital 2 of Kyiv station ( Site 2812)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>03049</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380997350900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>F.G.Yanovskyy Institute of Phthisiology and Pulmonology ( Site 2808)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380633912378</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>F.G.Yanovskyy Institute of Phthisiology and Pulmonology ( Site 2819)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380506818179</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odesa regional clinical hospital ( Site 2804)</name>
      <address>
        <city>Odesa</city>
        <state>Odeska Oblast</state>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380503907846</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Polyclinic N20 ( Site 2806)</name>
      <address>
        <city>Odesa</city>
        <state>Odeska Oblast</state>
        <zip>65114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380674826603</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Poltava City Clinical Hospital -1 ( Site 2813)</name>
      <address>
        <city>Poltava</city>
        <state>Poltavska Oblast</state>
        <zip>36039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380505858953</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Private Small-Scale Enterprise Medical Centre &quot;Pulse&quot; ( Site 2809)</name>
      <address>
        <city>Vinnytsya</city>
        <state>Vinnytska Oblast</state>
        <zip>21001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380672522328</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Volyn Regional Clinical Hospital ( Site 2816)</name>
      <address>
        <city>Lutsk</city>
        <state>Volynska Oblast</state>
        <zip>43005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380505470790</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Walk Surgery ( Site 2700)</name>
      <address>
        <city>Yate</city>
        <state>South Gloucestershire</state>
        <zip>BS37 4AX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4401454 272222</phone>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Germany</country>
    <country>Guatemala</country>
    <country>Israel</country>
    <country>Korea, Republic of</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cough</keyword>
  <keyword>Urinary Incontinence, Stress</keyword>
  <keyword>Respiration disorders</keyword>
  <keyword>Respiratory tract diseases</keyword>
  <keyword>Signs and symptoms, respiratory</keyword>
  <keyword>Signs and symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf</ipd_description>
    <ipd_url>http://engagezone.msd.com/ds_documentation.php</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

